(Q33360112)

26 July 2017

1 reference

title

Nephrotoxic aspects of cyclosporine (English)

1 reference

26 July 2017

1 reference

4

Remuzzi G

1 reference

26 July 2017

1

Cattaneo D

1 reference

26 July 2017

Perico N

2

1 reference

PubMed ID

15041344

26 July 2017

Gaspari F

series ordinal

3

1 reference

PubMed ID

15041344

26 July 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Transplantation Proceedings

26 July 2017

1 reference

26 July 2017

36

1 reference

26 July 2017

234S-239S

1 reference

26 July 2017

2 Suppl

1 reference

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Pharmacology of immunosuppressive medications used in renal diseases and transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Cyclosporine and the renin-angiotensin axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

The effect of conversion from cyclosporin to azathioprine on renin-containing cells in renal allograft biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Role of the renin-angiotensin system on the renal functional reserve in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Endothelial dysfunction in renal transplant recipients maintained on cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Cyclosporine-induced sympathetic activation and hypertension after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Oxidative stress in cyclosporin and azathioprine treated renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Role of intrarenal endothelin 1, endothelin 3, and angiotensin II expression in chronic cyclosporin A nephrotoxicity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Optimization of cyclosporine therapy in the Neoral era: abbreviated AUC, single blood sampling?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Routine renin-angiotensin system blockade in renal transplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Immunosuppression minimization: current and future trends in transplant immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Chronic renal failure after transplantation of a nonrenal organ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Elective cyclosporine withdrawal 1 year after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

Mechanisms of nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.01.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSPROCEED.2004.01.011

1 reference

26 July 2017

1 reference

PubMed ID

15041344